Literature DB >> 19470909

Fluorescent in situ hybridization for human epidermal growth factor receptor 2 assessment in breast cancer: is it applicable as a primary test?

Vincenzo Arena, Ilaria Pennacchia, Arnaldo Carbone, Arnaldo Capelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19470909     DOI： 10.1200/JCO.2009.23.2249

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.

Authors:  Jilong Yang; Da Yang; Yan Sun; Baocun Sun; Guowen Wang; Jonathan C Trent; Dejka M Araujo; Kexin Chen; Wei Zhang
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

2.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

3.  A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Authors:  Hiroaki Nitta; Brian D Kelly; Mary Padilla; Nikolaus Wick; Patrick Brunhoeber; Isaac Bai; Shalini Singh; Jim Ranger-Moore; Chris Bieniarz; Hitoshi Tsuda; Thomas M Grogan
Journal:  Diagn Pathol       Date:  2012-05-30       Impact factor: 2.644

4.  Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method.

Authors:  Elena García-García; Carlos Gómez-Martín; Bárbara Angulo; Esther Conde; Ana Suárez-Gauthier; Magdalena Adrados; Cristian Perna; José Luis Rodríguez-Peralto; Manuel Hidalgo; Fernando López-Ríos
Journal:  Histopathology       Date:  2011-07       Impact factor: 5.087
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.